Skip to main content

Table 1 Patients baseline characteristics

From: Outcomes and prognostic factors of patients treated for in-stent restenosis: a retrospective single-center experience

Characteristics Total n = 116 (%)
Sex, male 86 (74%)
Cardiovascular risk factors  
 Diabetes mellitus 64 (55.2%)
 Hypertension 72 (62.1%)
 Smoking (or stopped for less than 3 years) 70 (60.3%)
 LDL-cholesterol > 1.41 mmol/l 50 (43.9%)
 Family history of coronary artery disease 13 (11.2%)
Comorbidities  
 Chronic kidney disease (creatinine clearance < 60 ml/min) 47 (40.5%)
 Heart failure 9 (7.7%)
Statins therapy  
 High-dose statins therapy* 32 (27.6%)
  1. LDL low-density lipoprotein, LVEF left ventricular ejection fraction
  2. *Atorvastatin 80 mg once daily or Rosuvastatin 20 mg once daily